March 2012
Volume 53, Issue 14
Free
ARVO Annual Meeting Abstract  |   March 2012
Change in Choroidal Thickness Measurements in Diabetic Patients using Spectral Domain OCT
Author Affiliations & Notes
  • Steven L. Williams
    Ophthalmology, New England Eye Center, Tufts Medical Center, Boston, Massachusetts
  • Mehreen Adhi
    Ophthalmology, New England Eye Center, Tufts Medical Center, Boston, Massachusetts
  • Caio V. Regatieri
    Ophthalmology, New England Eye Center, Tufts Medical Center, Boston, Massachusetts
    Ophthalmology, Schepens Eye Res Inst - Harvard Medical, Boston, Massachusetts
  • Ahmad Al Wassia
    Ophthalmology, New England Eye Center, Tufts Medical Center, Boston, Massachusetts
  • Jason Zhang
    Ophthalmology, New England Eye Center, Tufts Medical Center, Boston, Massachusetts
  • Jay S. Duker
    Ophthalmology, New England Eye Center, Boston, Massachusetts
  • Nadia Waheed
    Ophthalmology, New England Eye Center, Tufts Medical Center, Boston, Massachusetts
  • Footnotes
    Commercial Relationships  Steven L. Williams, None; Mehreen Adhi, None; Caio V. Regatieri, None; Ahmad Al Wassia, None; Jason Zhang, None; Jay S. Duker, None; Nadia Waheed, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science March 2012, Vol.53, 2118. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Steven L. Williams, Mehreen Adhi, Caio V. Regatieri, Ahmad Al Wassia, Jason Zhang, Jay S. Duker, Nadia Waheed; Change in Choroidal Thickness Measurements in Diabetic Patients using Spectral Domain OCT. Invest. Ophthalmol. Vis. Sci. 2012;53(14):2118.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : To determine if the choroidal thickness in patients with diabetic retinopathy (DR) changes over time.

Methods: : A retrospective case review (2009 - present) identified 28 consecutive patients with DR, who underwent at least 2 foveal OCT scans, at least 6 months apart, using the Cirrus high definition OCT 1-line scanning protocol (Carl Zeiss Meditech Inc, Dublin, California, USA). The eye with the most advanced DR was selected as the study eye. DR was categorized into three groups based on clinical and OCT findings: non-proliferative DR (NPDR) (9 eyes), diabetic macula edema (DME) (10 eyes), or proliferative DR (PDR) (9 eyes). Subfoveal and parafoveal choroidal thickness measurements were manually calculated using the Cirrus linear measurement tool. In addition, choroidal thickness measurements from age-matched normal patients were used as controls. Differences between the respective DR groups at baseline and over time were analyzed and compared to age-matched controls.

Results: : No difference in choroidal thickness was detected between the NPDR patients and controls (p> 0.05). However, choroidal thickness was statistically significantly thinner in DME and PDR eyes compared to controls (p< 0.05 and p< 0.05, respectively). The average length of follow-up among all groups was 387 days. With a minimum of follow-up of 6 months, subfoveal choroidal thickness changed by -3.78 μm in the NPDR group (p = 0.747), -5.3 μm in the DME group (p = 0.739), and -12.44 μm in the PDR group (p = 0.339).

Conclusions: : Choroidal thickness appears to be decreased in patients with advanced diabetic retinopathy when compared to age-matched controls. Although reduced at baseline, choroidal thickness in diabetics does not appear to change appreciably over approximately one year. Longer term follow-up may be needed to better characterize the effect of advanced diabetic retinopathy on choroidal thickness.

Keywords: diabetes • choroid • imaging/image analysis: clinical 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×